{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:23:11Z","timestamp":1746346991813},"reference-count":26,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2021,7,21]]},"DOI":"10.1253\/circj.cj-20-0883","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T18:18:49Z","timestamp":1618942729000},"page":"1314-1320","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and Safety of SATAKE HotBalloon&lt;sup&gt;\u00ae&lt;\/sup&gt; Catheter for Treatment of Paroxysmal Atrial Fibrillation\u3000\u2015 A Post-Marketing Surveillance Study \u2015"],"prefix":"10.1253","volume":"85","author":[{"given":"Yukihiko","family":"Yoshida","sequence":"first","affiliation":[{"name":"Japanese Red Cross Nagoya Dai-ni Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teiichi","family":"Yamane","sequence":"additional","affiliation":[{"name":"Jikei University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Nakahara","sequence":"additional","affiliation":[{"name":"Dokkyo Medical University Saitama Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kobori","sequence":"additional","affiliation":[{"name":"Kobe City Medical Center General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sohara","sequence":"additional","affiliation":[{"name":"Shonantobu General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Aonuma","sequence":"additional","affiliation":[{"name":"University of Tsukuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shutaro","family":"Satake","sequence":"additional","affiliation":[{"name":"Hayama Heart Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"HotBalloon PMS Study Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Packer DL, Bardy GH, Worley SJ, Smith MS, Cobb FR, Coleman RE, et al. Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction. <i>Am J Cardiol<\/i> 1986; 57: 563\u2013570.","DOI":"10.1016\/0002-9149(86)90836-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bjorck S, Palaszewski B, Friberg L, Bergfeldt L. Atrial \ufb01brillation, stroke risk, and warfarin therapy revisited: A population-based study. <i>Stroke<\/i> 2013; 44: 3103\u20133108.","DOI":"10.1161\/STROKEAHA.113.002329"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Haim M, Hoshen M, Reges O, Rabi Y, Balicer R, Leibowitz M. Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial \ufb01brillation. <i>J Am Heart Assoc<\/i> 2015; 4: e001486.","DOI":"10.1161\/JAHA.114.001486"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial \ufb01brillation: European perspective. <i>Clin Epidemiol<\/i> 2014; 6: 213\u2013220.","DOI":"10.2147\/CLEP.S47385"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. McManus DD, Rienstra M, Benjamin EJ. An update on the prognosis of patients with atrial \ufb01brillation. <i>Circulation<\/i> 2012; 126: e143\u2013e146.","DOI":"10.1161\/CIRCULATIONAHA.112.129759"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ball J, Carrington MJ, McMurray JJ, Stewart S. Atrial \ufb01brillation: Pro\ufb01le and burden of an evolving epidemic in the 21st century. <i>Int J Cardiol<\/i> 2013; 167: 1807\u20131824.","DOI":"10.1016\/j.ijcard.2012.12.093"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial \ufb01brillation: Population-based estimates. <i>Am J Cardiol<\/i> 1998; 82: 2N\u20139N.","DOI":"10.1016\/S0002-9149(98)00583-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nguyen TN, Hilmer SN, Cumming RG. Review of epidemiology and management of atrial \ufb01brillation in developing countries. <i>Int J Cardiol<\/i> 2013; 167: 2412\u20132420.","DOI":"10.1016\/j.ijcard.2013.01.184"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P, et al. Variations in cause and management of atrial \ufb01brillation in a prospective registry of 15,400 emergency department patients in 46 countries: The RE-LY Atrial Fibrillation Registry. <i>Circulation<\/i> 2014; 129: 1568\u20131576.","DOI":"10.1161\/CIRCULATIONAHA.113.005451"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Chiang CE, Naditch-Brule L, Murin J, Goethals M, Inoue H, O\u2019Neill J, et al. Distribution and risk pro\ufb01le of paroxysmal, persistent, and permanent atrial \ufb01brillation in routine clinical practice: Insight from the real-life global survey evaluating patients with atrial \ufb01brillation international registry. <i>Circ Arrhythm Electrophysiol<\/i> 2012; 5: 632\u2013639.","DOI":"10.1161\/CIRCEP.112.970749"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, et al. Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination. <i>Int J Cardiol<\/i> 2009; 137: 102\u2013107.","DOI":"10.1016\/j.ijcard.2008.06.029"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial \ufb01brillation in the European Union, from 2000 to 2060. <i>Eur Heart J<\/i> 2013; 34: 2746\u20132751.","DOI":"10.1093\/eurheartj\/eht280"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, et al. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation. <i>Am Heart J<\/i> 2005; 149: 489\u2013496.","DOI":"10.1016\/j.ahj.2004.09.053"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013): Digest version. <i>Circ J<\/i> 2014; 78: 1997\u20132021.","DOI":"10.1253\/circj.CJ-66-0092"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ha\u00efssaguerre M, Ja\u00efs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. <i>N Engl J Med<\/i> 1998; 339: 659\u2013666.","DOI":"10.1056\/NEJM199809033391003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. <i>Circulation<\/i> 2005; 111: 1100\u20131105.","DOI":"10.1161\/01.CIR.0000157153.30978.67"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. <i>Circulation<\/i> 2002; 105: 1077\u20131081.","DOI":"10.1161\/hc0902.104712"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Oral H, Knight BP, Ozaydin M, Chugh A, Lai SW, Scharf C, et al. Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: Feasibility and mechanistic insights. <i>Circulation<\/i> 2002; 106: 1256\u20131262.","DOI":"10.1161\/01.CIR.0000027821.55835.00"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tanaka K, Satake S, Saito S, Takahashi S, Hiroe Y, Miyashita Y, et al. A new radiofrequency thermal balloon catheter for pulmonary vein isolation. <i>J Am Coll Cardiol<\/i> 2001; 38: 2079\u20132086.","DOI":"10.1016\/S0735-1097(01)01666-7"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Satake S, Tanaka K, Saito S, Tanaka S, Sohara H, Hiroe Y, et al. Usefulness of a new radiofrequency thermal balloon catheter for pulmonary vein isolation: A new device for treatment of atrial fibrillation. <i>J Cardiovasc Electrophysiol<\/i> 2003; 14: 609\u2013615.","DOI":"10.1046\/j.1540-8167.2003.02577.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sohara H, Takeda H, Ueno H, Oda T, Satake S. Feasibility of the radiofrequency hot balloon catheter for isolation of the posterior left atrium and pulmonary veins for the treatment of atrial fibrillation. <i>Circ Arrhythm Electrophysiol<\/i> 2009; 2: 225\u2013232.","DOI":"10.1161\/CIRCEP.108.817205"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sohara H, Ohe T, Okumura K, Naito S, Hirao K, Shoda M, et al. HotBalloon ablation of the pulmonary veins for paroxysmal AF: A multicenter randomized trial in Japan. <i>J Am Coll Cardiol<\/i> 2016; 68: 2747\u20132757.","DOI":"10.1016\/j.jacc.2016.10.037"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sohara H, Satake S, Takeda H, Yamaguchi Y, Nagusu N. Prevalence of esophageal ulceration after atrial fibrillation ablation with the hot balloon ablation catheter: What is the value of esophageal cooling? <i>J Cardiovasc Electrophysiol<\/i> 2014; 25: 686\u2013692.","DOI":"10.1111\/jce.12394"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Dukkipati SR, Cuoco F, Kutinsky I, Aryana A, Bahnson TD, Lakkireddy D, et al. Pulmonary vein isolation using the visually guided laser balloon: A prospective, multicenter, and randomized comparison to standard radiofrequency ablation. <i>J Am Coll Cardiol<\/i> 2015; 66: 1350\u20131360.","DOI":"10.1016\/j.jacc.2015.07.036"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Okumura K, Matsumoto K, Kobayashi Y, Nogami A, Hokanson RB, Kueffer F, et al. Safety and efficacy of cryoballoon ablation for paroxysmal atrial fibrillation in Japan: Results from the Japanese Prospective Post-Market Surveillance Study. <i>Circ J<\/i> 2016; 80: 1744\u20131749.","DOI":"10.1253\/circj.CJ-16-0285"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: First results of the North American Arctic Front (STOP AF) pivotal trial. <i>J Am Coll Cardiol<\/i> 2013; 61: 1713\u20131723.","DOI":"10.1016\/j.jacc.2012.11.064"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/8\/85_CJ-20-0883\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T23:14:21Z","timestamp":1627082061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/85\/8\/85_CJ-20-0883\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-20-0883","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"type":"print","value":"1346-9843"},{"type":"electronic","value":"1347-4820"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"article-number":"CJ-20-0883"}}